Story perspectives

China Charges Ex-AstraZeneca Chief Amid Fraud Investigations

2/11/2026

Summary

Story summary

China charged Leon Wang, former head of AstraZeneca, with medical insurance fraud, unlawful collection of personal information, and illegal trade.
Wang was detained in October 2024 amid investigations into AstraZeneca's operations, leading to the indictment.
In November 2024, AstraZeneca confirmed charges against two other executives.
The company has committed $15 billion to China and signed a weight loss drug licensing deal, signaling a strategic pivot despite legal challenges.

1 of 1

Story summary

China charged Leon Wang, former head of AstraZeneca, with medical insurance fraud, unlawful collection of personal information, and illegal trade.
Wang was detained in October 2024 amid investigations into AstraZeneca's operations, leading to the indictment.
In November 2024, AstraZeneca confirmed charges against two other executives.
The company has committed $15 billion to China and signed a weight loss drug licensing deal, signaling a strategic pivot despite legal challenges.